The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Predictive and Presymptomatic Testing Market Research Report 2025

Global Predictive and Presymptomatic Testing Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1953947

No of Pages : 80

Ask Your Query
Synopsis
Predictive genetic testing searches for genetic changes, or mutations, that are linked to disease. These tests are done before you show any signs of a disease. 
The global Predictive and Presymptomatic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Predictive and Presymptomatic Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Predictive and Presymptomatic Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Predictive and Presymptomatic Testing in Breast and Ovarian Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Predictive and Presymptomatic Testing include 23andMe, Inc., Abbott Molecular, Inc., BioAxis DNA Research Centre Private Limited, Color Genomics, Inc., Direct Laboratory Services LLC (DirectLabs), Gene by Gene Ltd., Genomic Diagnostics, Mapmygenome and Myriad Genetics, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Predictive and Presymptomatic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Predictive and Presymptomatic Testing.
Report Scope
The Predictive and Presymptomatic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Predictive and Presymptomatic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Predictive and Presymptomatic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
23andMe, Inc.
Abbott Molecular, Inc.
BioAxis DNA Research Centre Private Limited
Color Genomics, Inc.
Direct Laboratory Services LLC (DirectLabs)
Gene by Gene Ltd.
Genomic Diagnostics
Mapmygenome
Myriad Genetics, Inc.
Pathway Genomics Corporation
Positive Bioscience, Inc.
Quest Diagnostics, Inc.
Segment by Type
Presymptomatic Testing
Predispositional Testing
Segment by Application
Breast and Ovarian Cancer
Colorectal Cancer
Alzheimer's Disease
Multiple Endocrine Neoplasia Type 2
Haemochromatosis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Predictive and Presymptomatic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Predictive and Presymptomatic Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Presymptomatic Testing
1.2.3 Predispositional Testing
1.3 Market by Application
1.3.1 Global Predictive and Presymptomatic Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Breast and Ovarian Cancer
1.3.3 Colorectal Cancer
1.3.4 Alzheimer's Disease
1.3.5 Multiple Endocrine Neoplasia Type 2
1.3.6 Haemochromatosis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Predictive and Presymptomatic Testing Market Perspective (2019-2030)
2.2 Predictive and Presymptomatic Testing Growth Trends by Region
2.2.1 Global Predictive and Presymptomatic Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Predictive and Presymptomatic Testing Historic Market Size by Region (2019-2024)
2.2.3 Predictive and Presymptomatic Testing Forecasted Market Size by Region (2025-2030)
2.3 Predictive and Presymptomatic Testing Market Dynamics
2.3.1 Predictive and Presymptomatic Testing Industry Trends
2.3.2 Predictive and Presymptomatic Testing Market Drivers
2.3.3 Predictive and Presymptomatic Testing Market Challenges
2.3.4 Predictive and Presymptomatic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Predictive and Presymptomatic Testing Players by Revenue
3.1.1 Global Top Predictive and Presymptomatic Testing Players by Revenue (2019-2024)
3.1.2 Global Predictive and Presymptomatic Testing Revenue Market Share by Players (2019-2024)
3.2 Global Predictive and Presymptomatic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Predictive and Presymptomatic Testing Revenue
3.4 Global Predictive and Presymptomatic Testing Market Concentration Ratio
3.4.1 Global Predictive and Presymptomatic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Predictive and Presymptomatic Testing Revenue in 2023
3.5 Predictive and Presymptomatic Testing Key Players Head office and Area Served
3.6 Key Players Predictive and Presymptomatic Testing Product Solution and Service
3.7 Date of Enter into Predictive and Presymptomatic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Predictive and Presymptomatic Testing Breakdown Data by Type
4.1 Global Predictive and Presymptomatic Testing Historic Market Size by Type (2019-2024)
4.2 Global Predictive and Presymptomatic Testing Forecasted Market Size by Type (2025-2030)
5 Predictive and Presymptomatic Testing Breakdown Data by Application
5.1 Global Predictive and Presymptomatic Testing Historic Market Size by Application (2019-2024)
5.2 Global Predictive and Presymptomatic Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Predictive and Presymptomatic Testing Market Size (2019-2030)
6.2 North America Predictive and Presymptomatic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Predictive and Presymptomatic Testing Market Size by Country (2019-2024)
6.4 North America Predictive and Presymptomatic Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Predictive and Presymptomatic Testing Market Size (2019-2030)
7.2 Europe Predictive and Presymptomatic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Predictive and Presymptomatic Testing Market Size by Country (2019-2024)
7.4 Europe Predictive and Presymptomatic Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Predictive and Presymptomatic Testing Market Size (2019-2030)
8.2 Asia-Pacific Predictive and Presymptomatic Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Predictive and Presymptomatic Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Predictive and Presymptomatic Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Predictive and Presymptomatic Testing Market Size (2019-2030)
9.2 Latin America Predictive and Presymptomatic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Predictive and Presymptomatic Testing Market Size by Country (2019-2024)
9.4 Latin America Predictive and Presymptomatic Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Predictive and Presymptomatic Testing Market Size (2019-2030)
10.2 Middle East & Africa Predictive and Presymptomatic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Predictive and Presymptomatic Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Predictive and Presymptomatic Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 23andMe, Inc.
11.1.1 23andMe, Inc. Company Detail
11.1.2 23andMe, Inc. Business Overview
11.1.3 23andMe, Inc. Predictive and Presymptomatic Testing Introduction
11.1.4 23andMe, Inc. Revenue in Predictive and Presymptomatic Testing Business (2019-2024)
11.1.5 23andMe, Inc. Recent Development
11.2 Abbott Molecular, Inc.
11.2.1 Abbott Molecular, Inc. Company Detail
11.2.2 Abbott Molecular, Inc. Business Overview
11.2.3 Abbott Molecular, Inc. Predictive and Presymptomatic Testing Introduction
11.2.4 Abbott Molecular, Inc. Revenue in Predictive and Presymptomatic Testing Business (2019-2024)
11.2.5 Abbott Molecular, Inc. Recent Development
11.3 BioAxis DNA Research Centre Private Limited
11.3.1 BioAxis DNA Research Centre Private Limited Company Detail
11.3.2 BioAxis DNA Research Centre Private Limited Business Overview
11.3.3 BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Introduction
11.3.4 BioAxis DNA Research Centre Private Limited Revenue in Predictive and Presymptomatic Testing Business (2019-2024)
11.3.5 BioAxis DNA Research Centre Private Limited Recent Development
11.4 Color Genomics, Inc.
11.4.1 Color Genomics, Inc. Company Detail
11.4.2 Color Genomics, Inc. Business Overview
11.4.3 Color Genomics, Inc. Predictive and Presymptomatic Testing Introduction
11.4.4 Color Genomics, Inc. Revenue in Predictive and Presymptomatic Testing Business (2019-2024)
11.4.5 Color Genomics, Inc. Recent Development
11.5 Direct Laboratory Services LLC (DirectLabs)
11.5.1 Direct Laboratory Services LLC (DirectLabs) Company Detail
11.5.2 Direct Laboratory Services LLC (DirectLabs) Business Overview
11.5.3 Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Introduction
11.5.4 Direct Laboratory Services LLC (DirectLabs) Revenue in Predictive and Presymptomatic Testing Business (2019-2024)
11.5.5 Direct Laboratory Services LLC (DirectLabs) Recent Development
11.6 Gene by Gene Ltd.
11.6.1 Gene by Gene Ltd. Company Detail
11.6.2 Gene by Gene Ltd. Business Overview
11.6.3 Gene by Gene Ltd. Predictive and Presymptomatic Testing Introduction
11.6.4 Gene by Gene Ltd. Revenue in Predictive and Presymptomatic Testing Business (2019-2024)
11.6.5 Gene by Gene Ltd. Recent Development
11.7 Genomic Diagnostics
11.7.1 Genomic Diagnostics Company Detail
11.7.2 Genomic Diagnostics Business Overview
11.7.3 Genomic Diagnostics Predictive and Presymptomatic Testing Introduction
11.7.4 Genomic Diagnostics Revenue in Predictive and Presymptomatic Testing Business (2019-2024)
11.7.5 Genomic Diagnostics Recent Development
11.8 Mapmygenome
11.8.1 Mapmygenome Company Detail
11.8.2 Mapmygenome Business Overview
11.8.3 Mapmygenome Predictive and Presymptomatic Testing Introduction
11.8.4 Mapmygenome Revenue in Predictive and Presymptomatic Testing Business (2019-2024)
11.8.5 Mapmygenome Recent Development
11.9 Myriad Genetics, Inc.
11.9.1 Myriad Genetics, Inc. Company Detail
11.9.2 Myriad Genetics, Inc. Business Overview
11.9.3 Myriad Genetics, Inc. Predictive and Presymptomatic Testing Introduction
11.9.4 Myriad Genetics, Inc. Revenue in Predictive and Presymptomatic Testing Business (2019-2024)
11.9.5 Myriad Genetics, Inc. Recent Development
11.10 Pathway Genomics Corporation
11.10.1 Pathway Genomics Corporation Company Detail
11.10.2 Pathway Genomics Corporation Business Overview
11.10.3 Pathway Genomics Corporation Predictive and Presymptomatic Testing Introduction
11.10.4 Pathway Genomics Corporation Revenue in Predictive and Presymptomatic Testing Business (2019-2024)
11.10.5 Pathway Genomics Corporation Recent Development
11.11 Positive Bioscience, Inc.
11.11.1 Positive Bioscience, Inc. Company Detail
11.11.2 Positive Bioscience, Inc. Business Overview
11.11.3 Positive Bioscience, Inc. Predictive and Presymptomatic Testing Introduction
11.11.4 Positive Bioscience, Inc. Revenue in Predictive and Presymptomatic Testing Business (2019-2024)
11.11.5 Positive Bioscience, Inc. Recent Development
11.12 Quest Diagnostics, Inc.
11.12.1 Quest Diagnostics, Inc. Company Detail
11.12.2 Quest Diagnostics, Inc. Business Overview
11.12.3 Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Introduction
11.12.4 Quest Diagnostics, Inc. Revenue in Predictive and Presymptomatic Testing Business (2019-2024)
11.12.5 Quest Diagnostics, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Predictive and Presymptomatic Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Presymptomatic Testing
Table 3. Key Players of Predispositional Testing
Table 4. Global Predictive and Presymptomatic Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Predictive and Presymptomatic Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Predictive and Presymptomatic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Predictive and Presymptomatic Testing Market Share by Region (2019-2024)
Table 8. Global Predictive and Presymptomatic Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Predictive and Presymptomatic Testing Market Share by Region (2025-2030)
Table 10. Predictive and Presymptomatic Testing Market Trends
Table 11. Predictive and Presymptomatic Testing Market Drivers
Table 12. Predictive and Presymptomatic Testing Market Challenges
Table 13. Predictive and Presymptomatic Testing Market Restraints
Table 14. Global Predictive and Presymptomatic Testing Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Predictive and Presymptomatic Testing Market Share by Players (2019-2024)
Table 16. Global Top Predictive and Presymptomatic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Predictive and Presymptomatic Testing as of 2023)
Table 17. Ranking of Global Top Predictive and Presymptomatic Testing Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Predictive and Presymptomatic Testing Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Predictive and Presymptomatic Testing Product Solution and Service
Table 21. Date of Enter into Predictive and Presymptomatic Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Predictive and Presymptomatic Testing Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Predictive and Presymptomatic Testing Revenue Market Share by Type (2019-2024)
Table 25. Global Predictive and Presymptomatic Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Predictive and Presymptomatic Testing Revenue Market Share by Type (2025-2030)
Table 27. Global Predictive and Presymptomatic Testing Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Predictive and Presymptomatic Testing Revenue Market Share by Application (2019-2024)
Table 29. Global Predictive and Presymptomatic Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Predictive and Presymptomatic Testing Revenue Market Share by Application (2025-2030)
Table 31. North America Predictive and Presymptomatic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Predictive and Presymptomatic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Predictive and Presymptomatic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Predictive and Presymptomatic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Predictive and Presymptomatic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Predictive and Presymptomatic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Predictive and Presymptomatic Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Predictive and Presymptomatic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Predictive and Presymptomatic Testing Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Predictive and Presymptomatic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Predictive and Presymptomatic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Predictive and Presymptomatic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Predictive and Presymptomatic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Predictive and Presymptomatic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Predictive and Presymptomatic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 46. 23andMe, Inc. Company Detail
Table 47. 23andMe, Inc. Business Overview
Table 48. 23andMe, Inc. Predictive and Presymptomatic Testing Product
Table 49. 23andMe, Inc. Revenue in Predictive and Presymptomatic Testing Business (2019-2024) & (US$ Million)
Table 50. 23andMe, Inc. Recent Development
Table 51. Abbott Molecular, Inc. Company Detail
Table 52. Abbott Molecular, Inc. Business Overview
Table 53. Abbott Molecular, Inc. Predictive and Presymptomatic Testing Product
Table 54. Abbott Molecular, Inc. Revenue in Predictive and Presymptomatic Testing Business (2019-2024) & (US$ Million)
Table 55. Abbott Molecular, Inc. Recent Development
Table 56. BioAxis DNA Research Centre Private Limited Company Detail
Table 57. BioAxis DNA Research Centre Private Limited Business Overview
Table 58. BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Product
Table 59. BioAxis DNA Research Centre Private Limited Revenue in Predictive and Presymptomatic Testing Business (2019-2024) & (US$ Million)
Table 60. BioAxis DNA Research Centre Private Limited Recent Development
Table 61. Color Genomics, Inc. Company Detail
Table 62. Color Genomics, Inc. Business Overview
Table 63. Color Genomics, Inc. Predictive and Presymptomatic Testing Product
Table 64. Color Genomics, Inc. Revenue in Predictive and Presymptomatic Testing Business (2019-2024) & (US$ Million)
Table 65. Color Genomics, Inc. Recent Development
Table 66. Direct Laboratory Services LLC (DirectLabs) Company Detail
Table 67. Direct Laboratory Services LLC (DirectLabs) Business Overview
Table 68. Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Product
Table 69. Direct Laboratory Services LLC (DirectLabs) Revenue in Predictive and Presymptomatic Testing Business (2019-2024) & (US$ Million)
Table 70. Direct Laboratory Services LLC (DirectLabs) Recent Development
Table 71. Gene by Gene Ltd. Company Detail
Table 72. Gene by Gene Ltd. Business Overview
Table 73. Gene by Gene Ltd. Predictive and Presymptomatic Testing Product
Table 74. Gene by Gene Ltd. Revenue in Predictive and Presymptomatic Testing Business (2019-2024) & (US$ Million)
Table 75. Gene by Gene Ltd. Recent Development
Table 76. Genomic Diagnostics Company Detail
Table 77. Genomic Diagnostics Business Overview
Table 78. Genomic Diagnostics Predictive and Presymptomatic Testing Product
Table 79. Genomic Diagnostics Revenue in Predictive and Presymptomatic Testing Business (2019-2024) & (US$ Million)
Table 80. Genomic Diagnostics Recent Development
Table 81. Mapmygenome Company Detail
Table 82. Mapmygenome Business Overview
Table 83. Mapmygenome Predictive and Presymptomatic Testing Product
Table 84. Mapmygenome Revenue in Predictive and Presymptomatic Testing Business (2019-2024) & (US$ Million)
Table 85. Mapmygenome Recent Development
Table 86. Myriad Genetics, Inc. Company Detail
Table 87. Myriad Genetics, Inc. Business Overview
Table 88. Myriad Genetics, Inc. Predictive and Presymptomatic Testing Product
Table 89. Myriad Genetics, Inc. Revenue in Predictive and Presymptomatic Testing Business (2019-2024) & (US$ Million)
Table 90. Myriad Genetics, Inc. Recent Development
Table 91. Pathway Genomics Corporation Company Detail
Table 92. Pathway Genomics Corporation Business Overview
Table 93. Pathway Genomics Corporation Predictive and Presymptomatic Testing Product
Table 94. Pathway Genomics Corporation Revenue in Predictive and Presymptomatic Testing Business (2019-2024) & (US$ Million)
Table 95. Pathway Genomics Corporation Recent Development
Table 96. Positive Bioscience, Inc. Company Detail
Table 97. Positive Bioscience, Inc. Business Overview
Table 98. Positive Bioscience, Inc. Predictive and Presymptomatic Testing Product
Table 99. Positive Bioscience, Inc. Revenue in Predictive and Presymptomatic Testing Business (2019-2024) & (US$ Million)
Table 100. Positive Bioscience, Inc. Recent Development
Table 101. Quest Diagnostics, Inc. Company Detail
Table 102. Quest Diagnostics, Inc. Business Overview
Table 103. Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Product
Table 104. Quest Diagnostics, Inc. Revenue in Predictive and Presymptomatic Testing Business (2019-2024) & (US$ Million)
Table 105. Quest Diagnostics, Inc. Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Predictive and Presymptomatic Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Predictive and Presymptomatic Testing Market Share by Type: 2023 VS 2030
Figure 3. Presymptomatic Testing Features
Figure 4. Predispositional Testing Features
Figure 5. Global Predictive and Presymptomatic Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Predictive and Presymptomatic Testing Market Share by Application: 2023 VS 2030
Figure 7. Breast and Ovarian Cancer Case Studies
Figure 8. Colorectal Cancer Case Studies
Figure 9. Alzheimer's Disease Case Studies
Figure 10. Multiple Endocrine Neoplasia Type 2 Case Studies
Figure 11. Haemochromatosis Case Studies
Figure 12. Predictive and Presymptomatic Testing Report Years Considered
Figure 13. Global Predictive and Presymptomatic Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Predictive and Presymptomatic Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Predictive and Presymptomatic Testing Market Share by Region: 2023 VS 2030
Figure 16. Global Predictive and Presymptomatic Testing Market Share by Players in 2023
Figure 17. Global Top Predictive and Presymptomatic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Predictive and Presymptomatic Testing as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Predictive and Presymptomatic Testing Revenue in 2023
Figure 19. North America Predictive and Presymptomatic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Predictive and Presymptomatic Testing Market Share by Country (2019-2030)
Figure 21. United States Predictive and Presymptomatic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Predictive and Presymptomatic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Predictive and Presymptomatic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Predictive and Presymptomatic Testing Market Share by Country (2019-2030)
Figure 25. Germany Predictive and Presymptomatic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Predictive and Presymptomatic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Predictive and Presymptomatic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Predictive and Presymptomatic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Predictive and Presymptomatic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Predictive and Presymptomatic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Predictive and Presymptomatic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Predictive and Presymptomatic Testing Market Share by Region (2019-2030)
Figure 33. China Predictive and Presymptomatic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Predictive and Presymptomatic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Predictive and Presymptomatic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Predictive and Presymptomatic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Predictive and Presymptomatic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Predictive and Presymptomatic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Predictive and Presymptomatic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Predictive and Presymptomatic Testing Market Share by Country (2019-2030)
Figure 41. Mexico Predictive and Presymptomatic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Predictive and Presymptomatic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Predictive and Presymptomatic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Predictive and Presymptomatic Testing Market Share by Country (2019-2030)
Figure 45. Turkey Predictive and Presymptomatic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Predictive and Presymptomatic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. 23andMe, Inc. Revenue Growth Rate in Predictive and Presymptomatic Testing Business (2019-2024)
Figure 48. Abbott Molecular, Inc. Revenue Growth Rate in Predictive and Presymptomatic Testing Business (2019-2024)
Figure 49. BioAxis DNA Research Centre Private Limited Revenue Growth Rate in Predictive and Presymptomatic Testing Business (2019-2024)
Figure 50. Color Genomics, Inc. Revenue Growth Rate in Predictive and Presymptomatic Testing Business (2019-2024)
Figure 51. Direct Laboratory Services LLC (DirectLabs) Revenue Growth Rate in Predictive and Presymptomatic Testing Business (2019-2024)
Figure 52. Gene by Gene Ltd. Revenue Growth Rate in Predictive and Presymptomatic Testing Business (2019-2024)
Figure 53. Genomic Diagnostics Revenue Growth Rate in Predictive and Presymptomatic Testing Business (2019-2024)
Figure 54. Mapmygenome Revenue Growth Rate in Predictive and Presymptomatic Testing Business (2019-2024)
Figure 55. Myriad Genetics, Inc. Revenue Growth Rate in Predictive and Presymptomatic Testing Business (2019-2024)
Figure 56. Pathway Genomics Corporation Revenue Growth Rate in Predictive and Presymptomatic Testing Business (2019-2024)
Figure 57. Positive Bioscience, Inc. Revenue Growth Rate in Predictive and Presymptomatic Testing Business (2019-2024)
Figure 58. Quest Diagnostics, Inc. Revenue Growth Rate in Predictive and Presymptomatic Testing Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock